Estimating a cost‐effectiveness threshold for the Spanish NHS
Top Cited Papers
- 28 December 2017
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 27 (4), 746-761
- https://doi.org/10.1002/hec.3633
Abstract
The cost of generating a quality-adjusted life year (QALY) within a National Health Service provides an approximation of the average opportunity cost of funding decisions. This information can be used to inform a cost-effectiveness threshold. The aim of this paper is to estimate the cost per QALY at the Spanish National Health Service. We exploit variation across 17 regional health services and the exogenous changes in expenditure that took place as a consequence of the economic crisis over 5 years of data. We conduct fixed effect models and use an instrumental variable approach to test for potential remaining endogeneity. Our results show that health expenditure has a positive and significant effect on population health, with an average spending elasticity of 0.07. This translates into a cost per QALY of between 22,000€ and 25,000€. These values are below the cost-effectiveness threshold figure of 30,000€ commonly cited in Spain.Keywords
All Related Versions
Funding Information
- Ministerio de Sanidad, Servicios Sociales e Igualdad
This publication has 14 references indexed in Scilit:
- Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdHealth Technology Assessment, 2015
- Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferencesBMC Health Services Research, 2014
- Cuts drive health system reforms in SpainHealth Policy, 2013
- Searchers vs surveyors in estimating the monetary value of a QALY: resolving a nasty dilemma for NICEHealth Economics, Policy and Law, 2011
- Comparing costs and outcomes across programmes of health careHealth Economics, 2011
- Trying to estimate a monetary value for the QALYJournal of Health Economics, 2009
- Does health care spending improve health outcomes? Evidence from English programme budgeting dataJournal of Health Economics, 2008
- Sources of U.S. longevity increase, 1960–2001The Quarterly Review of Economics and Finance, 2004
- ¿Qué es una tecnología sanitaria eficiente en España?Gaceta Sanitaria, 2002